These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28585556)

  • 1. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Kamal S; Khan MA; Seth A; Cholankeril G; Gupta D; Singh U; Kamal F; Howden CW; Stave C; Nair S; Satapathy SK; Ahmed A
    Am J Gastroenterol; 2017 Oct; 112(10):1495-1505. PubMed ID: 28585556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Kim RG; Loomba R; Prokop LJ; Singh S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1521-1530.e8. PubMed ID: 28479502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL
    Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?
    Price JC; Tien PC
    Am J Gastroenterol; 2017 Oct; 112(10):1506-1507. PubMed ID: 28978973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Ma X; Sun D; Li C; Ying J; Yan Y
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):533-542. PubMed ID: 28866088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.
    Farooqui MT; Khan MA; Cholankeril G; Khan Z; Mohammed Abdul MK; Li AA; Shah N; Wu L; Haq K; Solanki S; Kim D; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):149-156. PubMed ID: 30234644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.
    Wong JC; Chan HL; Tse YK; Yip TC; Wong VW; Wong GL
    Aliment Pharmacol Ther; 2017 Nov; 46(10):1001-1010. PubMed ID: 28940673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.
    Simon TG; King LY; Zheng H; Chung RT
    J Hepatol; 2015 Jan; 62(1):18-23. PubMed ID: 25135867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
    Yang YH; Chen WC; Tsan YT; Chen MJ; Shih WT; Tsai YH; Chen PC
    J Hepatol; 2015 Nov; 63(5):1111-7. PubMed ID: 26196278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.
    Sharma R; Simon TG; Hagström H; Lochhead P; Roelstraete B; Söderling J; Verna EC; Emond J; Ludvigsson JF
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):749-759.e19. PubMed ID: 37121528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis.
    Chen T; Zuo X; Wang S; Yu P; Yuan J; Wei S; Chen J; Sun Y; Gao Y; Li X
    Medicine (Baltimore); 2020 May; 99(19):e20296. PubMed ID: 32384521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.
    Gu Y; Yang X; Liang H; Li D
    BMC Gastroenterol; 2019 Dec; 19(1):231. PubMed ID: 31888534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
    Vargas JI; Arrese M; Shah VH; Arab JP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Huang YW; Lee CL; Yang SS; Fu SC; Chen YY; Wang TC; Hu JT; Chen DS
    Am J Gastroenterol; 2016 Jul; 111(7):976-85. PubMed ID: 27166128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
    Kaplan DE; Mehta R; Garcia-Tsao G; Albrecht J; Aytaman A; Baffy G; Bajaj J; Hernaez R; Hunt K; Ioannou G; Johnson K; Kanwal F; Lee TH; Monto A; Pandya P; Schaubel D; Taddei TH
    Contemp Clin Trials; 2021 May; 104():106367. PubMed ID: 33771685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials.
    Xia DK; Hu ZG; Tian YF; Zeng FJ
    Drug Des Devel Ther; 2019; 13():405-422. PubMed ID: 30774306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
    Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
    Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants.
    Vahedian-Azimi A; Shojaie S; Banach M; Heidari F; Cicero AFG; Khoshfetrat M; Jamialahmadi T; Sahebkar A
    Ann Med; 2021 Dec; 53(1):1227-1242. PubMed ID: 34296976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.